NCT03870815

Long-term Outcomes and Prognostic Factors in Patient Undergoing CABG or PCI

Status unknown Last updated 12 April 2023

What this trial tests

trial testing CABG in Ischemic Heart Disease in 10,000 participants. Status unknown.

Timeline

27 February 2019

Primary endpoint
31 December 2025

28 February 2026

Quick facts

Lead sponsor	Samsung Medical Center
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	10,000
Start date	27 February 2019
Primary completion	31 December 2025
Estimated completion	28 February 2026
Sites	1 location across South Korea

Drugs / interventions tested

• CABG
• PCI

Conditions studied

• Ischemic Heart Disease — all drugs for Ischemic Heart Disease →

Sponsor

Samsung Medical Center

Who can join

18 and older, any sex, with Ischemic Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. To evaluate the long-term clinical outcomes and prognostic factors in patients with coronary artery disease undergoing coronary artery bypass graft surgery.
2. To evaluate the long-term clinical outcomes and prognostic factors in patients with coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

1. Use of intravascular ultrasound and long-term cardiac death or myocardial infarction in patients receiving current generation drug-eluting stents.
   Lee SY, Choi KH, Song YB, Park TK, et al · · 2022 · cited 16× · PMID 35581318 · DOI 10.1038/s41598-022-12339-6
2. Differential effects of dual antiplatelet therapy in patients presented with acute coronary syndrome vs. stable ischaemic heart disease after coronary artery bypass grafting.
   Choi KH, Song YB, Jeong DS, Jang YH, et al · · 2021 · cited 9× · PMID 33075126 · DOI 10.1093/ehjcvp/pvaa080
3. Drug-Coated Balloon Angioplasty in Patients Undergoing Complex Percutaneous Coronary Intervention.
   Joh HS, Kwon W, Shin D, Lee SH, et al · · 2024 · cited 8× · PMID 39101114 · DOI 10.1016/j.jacasi.2024.04.007
4. Intravascular Imaging-Guided Percutaneous Coronary Intervention Before and After Standardized Optimization Protocols.
   Kwon W, Hong D, Choi KH, Lee SH, et al · · 2024 · cited 7× · PMID 38267144 · DOI 10.1016/j.jcin.2023.10.062
5. Clinical Impact of Sarcopenia Screening on Long-Term Mortality in Patients Undergoing Coronary Bypass Grafting.
   Lee SH, Jo J, Yang JH, Kim SM, et al · · 2024 · cited 4× · PMID 39513369 · DOI 10.1002/jcsm.13645
6. The Pullback Pressure Gradient: A Physiologic Index to Differentiate Focal From Diffuse Coronary Artery Disease.
   Carvalho PEP, Collet C, De Bruyne B, Munhoz D, et al · · 2025 · cited 3× · PMID 40286353 · DOI 10.1016/j.jacadv.2025.101679
7. Outcomes of intravascular imaging-guided percutaneous coronary intervention according to lesion complexity.
   Lee SY, Lee SJ, Kwon W, Lee SH, et al · · 2025 · cited 3× · PMID 39901632 · DOI 10.4244/eij-d-24-00755
8. Impact of gender on mid-term prognosis of patients undergoing coronary artery bypass grafting.
   Jang WJ, Choi KH, Kim J, Yang JH, et al · · 2023 · cited 3× · PMID 36862681 · DOI 10.1371/journal.pone.0279030